Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10129 - 10136 of 12008 results
SEC Uses Data Analytics to Identify and Punish Late Form Filers
September 12, 2014| Blog| Viewpoint
Upcoming Webinar on October 8th: Wage & Hour Compliance for the Auto Dealer Industry (CLE credit available)
September 11, 2014| Blog| Viewpoint
6 Little Known Facts About H-1B Visas
September 11, 2014| Blog| Viewpoint
AB 1103 Update: Postponement of Certain Nonresidential Building Energy Use Disclosure Requirements
September 11, 2014| Alert| Viewpoint
Calling for Judicial/Legislative Intervention in Unwarranted M&A Shareholder Litigation
September 11, 2014| Blog| Viewpoint
Government Issues New Rules for Religious Employers, But Health Plans, TPAs, And PBMs Are Still On The Hook To Provide Contraceptive Coverage
September 10, 2014| Blog| Viewpoint
Federation of State Medical Boards Releases Interstate Licensure Compact
September 10, 2014| Blog| Viewpoint
ML Strategies Energy and Environment Update: Week of 9/8/2014
September 9, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|